Peptide nucleic acid oligo


Ontology type: npg:Subject  | skos:Concept     


Concept Info

NAME

Peptide nucleic acid oligo

DESCRIPTION

Peptide nucleic acids are synthetic polymers that mimic the structure of DNA or RNA. PNAs are used in various molecular biology techniques involving specific recognition of a complementary DNA or RNA strand and have been investigated as the basis for diagnostics and antisense therapies.

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "id": "http://scigraph.springernature.com/ontologies/subjects/peptide-nucleic-acid-oligo", 
    "rdfs:label": "Peptide nucleic acid oligo", 
    "sdDataset": "onto_subjects", 
    "skos:broader": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/nucleic-acid-therapeutics"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/biologics"
      }
    ], 
    "skos:definition": [
      {
        "@language": "en", 
        "@value": "Peptide nucleic acids are synthetic polymers that mimic the structure of DNA or RNA. PNAs are used in various molecular biology techniques involving specific recognition of a complementary DNA or RNA strand and have been investigated as the basis for diagnostics and antisense therapies."
      }
    ], 
    "skos:inScheme": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/"
      }
    ], 
    "skos:prefLabel": [
      {
        "@language": "en", 
        "@value": "Peptide nucleic acid oligo"
      }
    ], 
    "type": [
      "http://ns.nature.com/terms/Subject", 
      "http://www.w3.org/2004/02/skos/core#Concept"
    ]
  }, 
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "id": "http://scigraph.springernature.com/ontologies/subjects/nucleic-acid-therapeutics", 
    "rdfs:label": "Nucleic-acid therapeutics", 
    "sdDataset": "onto_subjects", 
    "skos:broader": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/biologics"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/biotechnology"
      }
    ], 
    "skos:definition": [
      {
        "@language": "en", 
        "@value": "Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides, aptamers and small interfering RNAs, and are typically considered in cases where specific inhibition of the function of a particular gene involved in disease is thought to be therapeutically desirable. "
      }
    ], 
    "skos:inScheme": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/"
      }
    ], 
    "skos:narrower": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/locked-nucleic-acid"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/antagomir-and-rna-sponge"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/peptide-nucleic-acid-oligo"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/triplex-oligo"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/rnai-therapy"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/antisense-oligonucleotide-therapy"
      }
    ], 
    "skos:prefLabel": [
      {
        "@language": "en", 
        "@value": "Nucleic-acid therapeutics"
      }
    ], 
    "type": [
      "http://www.w3.org/2004/02/skos/core#Concept", 
      "http://ns.nature.com/terms/Subject"
    ]
  }, 
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "id": "http://scigraph.springernature.com/ontologies/subjects/biologics", 
    "rdfs:label": "Biologics", 
    "sdDataset": "onto_subjects", 
    "skos:altLabel": [
      {
        "@language": "en", 
        "@value": "Biologic medicine"
      }, 
      {
        "@language": "en", 
        "@value": "Biologic medicinal product"
      }, 
      {
        "@language": "en", 
        "@value": "Biological"
      }, 
      {
        "@language": "en", 
        "@value": "Biological Products"
      }, 
      {
        "@language": "en", 
        "@value": "Biologic Products"
      }, 
      {
        "@language": "en", 
        "@value": "Natural Products"
      }, 
      {
        "@language": "en", 
        "@value": "Biopharmaceutical"
      }
    ], 
    "skos:broader": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/drug-discovery"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/biotechnology"
      }
    ], 
    "skos:definition": [
      {
        "@language": "en", 
        "@value": "A biologic is a therapeutic substance that is produced through a biological process (often involving biotechnology methods), rather than chemical synthesis (as for traditional pharmaceuticals). Types of biologic include antibody therapies, vaccines, gene therapies and cell therapies. "
      }
    ], 
    "skos:inScheme": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/"
      }
    ], 
    "skos:narrower": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/antisense-oligonucleotide-therapy"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/triplex-oligo"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/gene-therapy"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/meganucleases"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/recombinant-protein-therapy"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/locked-nucleic-acid"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/rna-vaccines"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/recombinant-peptide-therapy"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/antibody-therapy"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/recombinant-vaccine"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/antibody-fragment-therapy"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/antagomir-and-rna-sponge"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/zinc-finger-nuclease"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/cell-therapies"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/sirnas"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/dna-vaccines"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/tal-effector-nuclease"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/nucleic-acid-therapeutics"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/peptide-nucleic-acid-oligo"
      }
    ], 
    "skos:prefLabel": [
      {
        "@language": "en", 
        "@value": "Biologics"
      }
    ], 
    "type": [
      "http://ns.nature.com/terms/Subject", 
      "http://www.w3.org/2004/02/skos/core#Concept"
    ]
  }, 
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "id": "http://www.w3.org/2004/02/skos/core#Concept", 
    "rdfs:subClassOf": [
      {
        "id": "http://www.w3.org/2004/02/skos/core#Concept"
      }, 
      {
        "id": "http://www.w3.org/2000/01/rdf-schema#Resource"
      }
    ], 
    "sdDataset": "for_codes", 
    "type": [
      "http://www.w3.org/2000/01/rdf-schema#Resource", 
      "http://www.w3.org/2000/01/rdf-schema#Class"
    ]
  }, 
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "dcterms:description": [
      {
        "@language": "en", 
        "@value": "The Nature Subjects Taxonomy is a polyhierarchical categorization of scholarly subject areas which are used for the indexing of content by Springer Nature."
      }
    ], 
    "dcterms:title": [
      {
        "@language": "en", 
        "@value": "Nature Subjects Taxonomy"
      }
    ], 
    "id": "http://scigraph.springernature.com/ontologies/subjects/", 
    "sdDataset": "onto_subjects", 
    "skos:hasTopConcept": [
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/physical-sciences"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/DEPRECATED"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/business-and-commerce"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/humanities"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/social-science"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/health-sciences"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/scientific-community-and-society"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/earth-and-environmental-sciences"
      }, 
      {
        "id": "http://scigraph.springernature.com/ontologies/subjects/biological-sciences"
      }
    ], 
    "type": [
      "http://www.w3.org/2004/02/skos/core#ConceptScheme"
    ]
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/ontologies/subjects/peptide-nucleic-acid-oligo'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/ontologies/subjects/peptide-nucleic-acid-oligo'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/ontologies/subjects/peptide-nucleic-acid-oligo'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/ontologies/subjects/peptide-nucleic-acid-oligo'


 

This table displays all metadata directly associated to this object as RDF triples.

78 TRIPLES      8 PREDICATES      11 URIs      4 LITERALS

Subject Predicate Object
1 sg:ontologies/subjects/peptide-nucleic-acid-oligo sgo:license sg:explorer/license/
2 sgo:sdDataset onto_subjects
3 rdf:type npg:Subject
4 skos:Concept
5 rdfs:label Peptide nucleic acid oligo
6 skos:broader sg:ontologies/subjects/biologics
7 sg:ontologies/subjects/nucleic-acid-therapeutics
8 skos:definition Peptide nucleic acids are synthetic polymers that mimic the structure of DNA or RNA. PNAs are used in various molecular biology techniques involving specific recognition of a complementary DNA or RNA strand and have been investigated as the basis for diagnostics and antisense therapies.
9 skos:inScheme sg:ontologies/subjects/
10 skos:prefLabel Peptide nucleic acid oligo
11 sg:ontologies/subjects/ dcterms:description The Nature Subjects Taxonomy is a polyhierarchical categorization of scholarly subject areas which are used for the indexing of content by Springer Nature.
12 dcterms:title Nature Subjects Taxonomy
13 sgo:sdDataset onto_subjects
14 rdf:type skos:ConceptScheme
15 skos:hasTopConcept sg:ontologies/subjects/DEPRECATED
16 sg:ontologies/subjects/biological-sciences
17 sg:ontologies/subjects/business-and-commerce
18 sg:ontologies/subjects/earth-and-environmental-sciences
19 sg:ontologies/subjects/health-sciences
20 sg:ontologies/subjects/humanities
21 sg:ontologies/subjects/physical-sciences
22 sg:ontologies/subjects/scientific-community-and-society
23 sg:ontologies/subjects/social-science
24 sg:ontologies/subjects/biologics sgo:sdDataset onto_subjects
25 rdf:type npg:Subject
26 skos:Concept
27 rdfs:label Biologics
28 skos:altLabel Biologic Products
29 Biologic medicinal product
30 Biologic medicine
31 Biological
32 Biological Products
33 Biopharmaceutical
34 Natural Products
35 skos:broader sg:ontologies/subjects/biotechnology
36 sg:ontologies/subjects/drug-discovery
37 skos:definition A biologic is a therapeutic substance that is produced through a biological process (often involving biotechnology methods), rather than chemical synthesis (as for traditional pharmaceuticals). Types of biologic include antibody therapies, vaccines, gene therapies and cell therapies.
38 skos:inScheme sg:ontologies/subjects/
39 skos:narrower sg:ontologies/subjects/antagomir-and-rna-sponge
40 sg:ontologies/subjects/antibody-fragment-therapy
41 sg:ontologies/subjects/antibody-therapy
42 sg:ontologies/subjects/antisense-oligonucleotide-therapy
43 sg:ontologies/subjects/cell-therapies
44 sg:ontologies/subjects/dna-vaccines
45 sg:ontologies/subjects/gene-therapy
46 sg:ontologies/subjects/locked-nucleic-acid
47 sg:ontologies/subjects/meganucleases
48 sg:ontologies/subjects/nucleic-acid-therapeutics
49 sg:ontologies/subjects/peptide-nucleic-acid-oligo
50 sg:ontologies/subjects/recombinant-peptide-therapy
51 sg:ontologies/subjects/recombinant-protein-therapy
52 sg:ontologies/subjects/recombinant-vaccine
53 sg:ontologies/subjects/rna-vaccines
54 sg:ontologies/subjects/sirnas
55 sg:ontologies/subjects/tal-effector-nuclease
56 sg:ontologies/subjects/triplex-oligo
57 sg:ontologies/subjects/zinc-finger-nuclease
58 skos:prefLabel Biologics
59 sg:ontologies/subjects/nucleic-acid-therapeutics sgo:sdDataset onto_subjects
60 rdf:type npg:Subject
61 skos:Concept
62 rdfs:label Nucleic-acid therapeutics
63 skos:broader sg:ontologies/subjects/biologics
64 sg:ontologies/subjects/biotechnology
65 skos:definition Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides, aptamers and small interfering RNAs, and are typically considered in cases where specific inhibition of the function of a particular gene involved in disease is thought to be therapeutically desirable.
66 skos:inScheme sg:ontologies/subjects/
67 skos:narrower sg:ontologies/subjects/antagomir-and-rna-sponge
68 sg:ontologies/subjects/antisense-oligonucleotide-therapy
69 sg:ontologies/subjects/locked-nucleic-acid
70 sg:ontologies/subjects/peptide-nucleic-acid-oligo
71 sg:ontologies/subjects/rnai-therapy
72 sg:ontologies/subjects/triplex-oligo
73 skos:prefLabel Nucleic-acid therapeutics
74 skos:Concept sgo:sdDataset for_codes
75 rdf:type rdfs:Class
76 rdfs:Resource
77 rdfs:subClassOf rdfs:Resource
78 skos:Concept
 




Preview window. Press ESC to close (or click here)


...